Hit and miss

The TARGET trial: hit or miss?

Over the past 8 years large-scale, placebo-controlled trials have established the efficacy of intravenous platelet glycoprotein (GP) IIb/IIIa inhibitors at reducing the 30-day composite of death, myocardial infarction, and urgent target vessel revascularization associated with percutaneous coronary angioplasty, atherectomy, and stent placement. Using abciximab, tirofiban, or eptifibatide, each ...

When does a hit = a miss?

The Simultaneous Proxy Evaluation (SPE) architecture allows one to evaluate implemented proxies in a live network environment and be able to make performance comparisons between black-box systems. When using a real workload on a live network with real content, SPE is additionally able to evaluate prefetching proxies. The SPE architecture requires, as a component, a proxy cache that serves all c...

Examining social facilitation in vigilance: a hit and a miss.

Vigilance is the ability of an observer to maintain attention for extended periods of time; however, performance tends to decline with time on watch, a pattern referred to as the vigilance decrement. Previous research has focused on factors that attenuate the decrement; however, one factor rarely studied is the effect of social facilitation. The purpose for the present investigation was to dete...

Estimating Cache Hit Rates from the Miss Sequence

This paper considers the problem of inferring cache hit rates from observations of references that miss in the cache. In the Web context, this is the problem of inferring a browser's cache hit rate by examining the requests that it issues to origin servers. We show that a case of this problem can be solved.

HIT or Miss - Studying Failures to Enable Success.